Wasatch Advisors’s Viemed Healthcare VMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,546,010
Closed -$10.7M 252
2025
Q2
$10.7M Buy
1,546,010
+240,346
+18% +$1.63M 0.06% 153
2025
Q1
$9.51M Sell
1,305,664
-22,024
-2% -$173K 0.05% 159
2024
Q4
$10.6M Sell
1,327,688
-521,196
-28% -$4.52M 0.05% 157
2024
Q3
$13.6M Buy
1,848,884
+303,277
+20% +$2.17M 0.07% 140
2024
Q2
$10.1M Buy
1,545,607
+382,673
+33% +$2.88M 0.05% 149
2024
Q1
$11M Hold
1,162,934
0.06% 155
2023
Q4
$9.13M Hold
1,162,934
0.05% 157
2023
Q3
$7.83M Buy
1,162,934
+75,089
+7% +$615K 0.05% 159
2023
Q2
$10.6M Sell
1,087,845
-209,634
-16% -$2.13M 0.06% 153
2023
Q1
$12.5M Sell
1,297,479
-105,313
-8% -$918K 0.08% 151
2022
Q4
$10.6M Buy
1,402,792
+19,728
+1% +$134K 0.07% 164
2022
Q3
$8.3M Sell
1,383,064
-186,978
-12% -$1.2M 0.06% 175
2022
Q2
$8.45M Buy
1,570,042
+1,250,910
+392% +$6.74M 0.05% 182
2022
Q1
$1.59M Buy
+319,132
New +$1.48M 0.01% 245
2020
Q3
Sell
-305,802
Closed -$2.93M 262
2020
Q2
$2.93M Sell
305,802
-619,083
-67% -$4.81M 0.02% 215
2020
Q1
$4.35M Buy
924,885
+184,645
+25% +$916K 0.05% 179
2019
Q4
$4.63M Sell
740,240
-64,989
-8% -$451K 0.04% 208
2019
Q3
$5.56M Buy
+805,229
New +$5.37M 0.05% 174

Other funds holding VMD

Wasatch Advisors's VMD Position: Q3 2025 in Review

Wasatch Advisors sold out of Viemed Healthcare (VMD) in Q3 2025, closing a stake of 1,546,010 shares — an estimated $10.7M sold.

Wasatch Advisors first reported a position in VMD in Q3 2019 and held it in 18 quarters. The position peaked at $13.6M in Q3 2024. 131 funds tracked by Wall St. Rank hold VMD as of Q3 2025.

  • Wasatch Advisors reported no remaining Viemed Healthcare position as of Q3 2025 after selling out during the quarter.
  • Wasatch Advisors sold 1,546,010 Viemed Healthcare shares in Q3 2025, an estimated $10.7M.
  • Wasatch Advisors first reported a position in Viemed Healthcare in Q3 2019 and held it in 18 quarters.
  • Wasatch Advisors's Viemed Healthcare position peaked at $13.6M in Q3 2024.
  • 131 funds tracked by Wall St. Rank held Viemed Healthcare as of Q3 2025.

Based on Wasatch Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.